BioDelivera
BioDelivera is a YC Fall 2026 (F26) company. Based in San Francisco, CA, USA. Team of 2.
About BioDelivera
Summary
BioDelivera builds a programmable delivery platform, called Guided Chimeric Vehicles (GCV™), that ferries genetic medicines, DNA, RNA, small molecules, or combinations of them directly to diseased cells without harming surrounding healthy tissue. The platform addresses the fundamental obstacle that has held back gene and cell therapies: getting the right payload to the right cells reliably. BioDelivera has validated the approach across tumors, muscle, and brain tissue and is extending it to further tissue types.
From the Y Combinator listing
Programmable drug delivery precisely targets only diseased cells
BioDelivera has developed proprietary GCV™, a drug delivery platform designed to travel through the body and selectively target diseased cells while sparing healthy ones. GCVs can carry genetic medicines, DNA, RNA, small molecules, or combinations of these at the same time. BioDelivera has demonstrated efficacy in tumors, muscle, and brain and is expanding to additional tissues. The company’s mission is to enable cures for every patient, across every disease.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Francisco, CA, USA
- 2
- Active
- Early
Founders (2)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works